Entries are now open for the EHP Awards 2027, inviting organisations and partnerships across the healthcare ecosystem to ...

Eli Lilly’s Foundayo (orforglipron) has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for weight loss and type 2 diabetes, with the UK being the first country in ...

Ipsen’s cabozantinib has been accepted by the Scottish Medicines Consortium (SMC) for restricted use within NHS Scotland to treat adults with advanced neuroendocrine tumours (NETs).

AstraZeneca has announced a NICE recommendation for two acalabrutinib-based combinations, expanding access to new first-line ...

BeOne Medicines has appointed Kandeepan Ganeshalingam as Vice-President, Head of Medical Affairs, Europe. Leading the Medical ...

The Healthcare Communications Association (HCA) has announce that Emma Kenny will be the new interim CEO, following the departure of current CEO Mike Dixon later this summer. Mike, who over the last ...

Novartis’ Pluvicto has been approved by the US FDA in combination with an androgen receptor pathway inhibitor (ARPI) for ...

Around 60,000 people in the US get pancreatic cancer each year, with an estimated 50,000 deaths projected annually ...

As biopharmas move towards Agentic Commercial, service evolution is key to delivering the frictionless, 24/7 experience HCPs ...

Meaningful engagement is not defined solely by trial outcomes, but by whether patients feel heard, informed and involved ...

Genesis Research Group today announced the appointment of Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR. She joins the Executive Leadership Team and will lead the company’s global ...